Surface Guided Radiation Therapy Devices Market Size, Share, Growth, Trends, and Global Industry Analysis: By Application (Breast Cancer, Head & Neck Cancer, Abdominal & Pelvic Cancer, Dermatology, Others), By End-User (Hospitals & Clinics, Diagnostic Centers, Others), and Region Forecast 2020-2031

Surface Guided Radiation Therapy Devices Market size was valued at US$ 169.7 million in 2024 and is expected to reach US$ 227.1 million by 2031, growing at a significant CAGR of 4.3% from 2025-2031. Surface guided radiation therapy (SGRT) uses technology to position and monitor the patient's external surface in order to ensure that they are in correct position throughout their radiation treatment. It provides transitional and rotational information of the patient's skin surface and offers the potential to improve the accuracy of setup.

The surface guided radiation therapy (SGRT) is used in both setup and therapy for breast, deep inspiration breath-hold (DIBH), head and neck, pediatrics and other indications. It is a rapidly growing technique that uses stereo vision technology to track patients' surface in 3D during radiotherapy. This report studies market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. The major market participants are adopting the strategies such as mergers and acquisitions to position themselves as strong players. In addition, the market report includes regulatory scenario and competition analysis with vividly illustrated the competition dashboard to assess the market competition.

Key Developments

• In March 2022, C-RAD has made agreement to supply its cutting-edge SGRT solution to a newly built proton therapy center in Texas, US. The agreement includes multiple systems and a multiyear service agreement.
• In October 2021, Vision RT introduced its latest product, DoseRTs, showcased at last year's ASTRO Annual Meeting. As the pioneer of SGRT, Vision RT now brings another world's first- eal-time patient monitoring and beam imaging, at the same time. DoseRT is born from combining the power of Cherenkov Imaging with BeamSites (DoseOptics LLC) and Vision RT's newest camera system, Horizon.
• In July 2019, C-RAD and Elekta entered into a sales and distribution agreement to distribute C-RAD’s cutting-edge SIGRT solutions in the North American and Mexican markets. The agreement enabled Elekta to offer C-RAD’s surface image-guided radiation therapy (SIGRT) technology for stereotactic radiosurgery (SRS), stereotactic body radiotherapy (SBRT), and motion management.
• In September 2020, C-RAD and Elekta expand their cooperation to distribute C-RAD’s cutting-edge SIGRT solutions in China. The Chinese market is one of the fastest-growing radiation therapy markets worldwide with huge potential.
• There are around ~65-75 SGRTs are installed on Elekta’s Linacs every year
• Most SGRT-systems installations are on traditional (C-arm) linear accelerators (linacs)
• North American partnership with Elekta as an initiative that could yield further market share gains, we find low-hanging fruit in outfitting Elekta’s existing installed base.